Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pessary and Progesterone for Preterm Birth Prevention (CAPP)
NCT03227705Completed
- Sponsor
- Université de Sherbrooke
- Start
- Jun 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in preterm birth (2 arms), sponsored by Université de Sherbrooke. Primary endpoint: Recruitment feasibility at 24 weeks. Started Jun 2018; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03227705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227705.